Loading
After surgery or radiotherapy to the armpit nodes, the arm can swell (lymphoedema). Measuring the arm before surgery and at check-ups can find swelling early, when a compression sleeve may stop it becoming permanent. Exercise, including weights, is safe. Infection raises the risk; the old bans on blood pressure, needles or flying are not well supported. Report arm swelling, heaviness or redness.
MASCC 2024 (Delphi, 55 experts, statements based on randomised trials and systematic reviews): prioritise people with axillary node dissection, axillary radiotherapy, early relative arm volume increase, many nodes removed and BMI of 30 or more; run prospective surveillance where resources allow (93.8% agreement), with a pre-surgical baseline, starting within 3 months of surgery, every 3 to 4 months in year 1 then every 6 to 12 months for at least 24 months; bioimpedance spectroscopy (L-Dex rise of 6.5 or more) or a 5 to under 10% volume increase or any arm symptom triggers a compression sleeve for at least 4 to 6 weeks; 10% or more triggers more intensive treatment; prophylactic compression sleeves, axillary reverse mapping and prophylactic lymphatic reconstruction are options where expertise and resources allow.
The APTA interventions guideline (2020) recommends prospective surveillance in high-risk groups (Grade C): a preoperative measurement with bioimpedance spectroscopy or volume, then every 3 months for the first year and twice a year for up to 5 years. Subclinical (ISL stage 0) lymphoedema may be treated with education, self-massage and compression garments (Grade C), escalating to complete decongestive therapy (CDT) if it persists. For early (stage I) lymphoedema, an individually fitted compression garment, an exercise programme and education are first-line (Grade A); CDT is used for moderate and late lymphoedema (stages II and III, Grade B), followed by home care with self-massage, a fitted garment and exercise (Grade B). Supervised progressive resistance training from at least one month after surgery is safe (Grade A) and aerobic exercise should be provided (Grade A); therapist manual lymphatic drainage may not reduce risk (Grade C), and a fitted compression garment for high-risk patients with exercise may reduce it (Grade B). PAL (n=154): slowly progressive weight lifting did not increase lymphoedema.
In the PREVENT trial (963 randomised, 879 analysed), surveillance by bioimpedance spectroscopy triggered a four-week compression sleeve less often than tape measurement (20.1 against 27.5 per cent), and fewer of those treated progressed to chronic lymphoedema needing CDT (7.9 against 19.2 per cent, relative risk 0.41). New cases kept appearing in years two and three, so the authors advise monitoring for at least three years. The APTA diagnosis guideline (2017) set bioimpedance cut-offs of an L-Dex above 7.1 without a baseline or more than 10 above baseline (Grade B); its authors updated the bioimpedance advice in 2018, which was not read.
On the traditional precautions, in a 3,041-measurement cohort blood draws, injections, blood pressure readings and flights were not associated with arm volume increase, while cellulitis was a risk; a 2024 evidence map prepared for the American Cancer Society and Lymphology Association of North America summit found the evidence sufficient to refute many of the previously claimed risk factors, and called a 'just in case' approach to education possibly inappropriate.
Why: Prevention and surveillance can be concentrated on the people most likely to develop swelling.
“Axillary lymph node dissection, use of post-operative radiotherapy, relative within-arm volume increase one month after surgery, greater number of lymph nodes dissected, and high body mass index were recommended as the most important risk factors to guide selection of patients for interventions to prevent BCRAL.”
Multinational Association of Supportive Care in Cancer 2024 · Delphi consensus (MASCC)
Why: Small changes are only meaningful against the person's own starting point.
“Monitoring with bioelectric impedance spectroscopy or volume measures may begin with a preoperative assessment, repeated every 3 months for the first year postoperatively, and then biannually for up to 5 years. (Grade C)”
APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 · Grade C
Why: Most early swelling appears within the first nine months, but new cases keep appearing in years two and three; changing methods makes readings incomparable.
“Patients should continue to be monitored for a minimum of 3 years following completion of cancer treatment. Specifically, careful targeted monitoring over the initial 9-month period is important.”
Why: Bioimpedance detects fluid build-up before the arm looks swollen; a tape measure still works when a machine is not available.
“2.3 In a prospective surveillance program, arm circumference (or volumetric) or lymphangiography/lymphoscintigraphy measurement is an alternative method to identify patients with subclinical/early stage lymphoedema for early treatment when bioimpedance spectroscopy is not available or there are resource limitations Consensus achieved in round 1 82.8% (53/64)”
Multinational Association of Supportive Care in Cancer 2024 · Consensus 82.8% (alternatives); 89.8% (bioimpedance as an option)
Why: What the person feels often comes before a measurable change.
“Self-reported symptoms of swelling, heaviness, and numbness should be investigated for early diagnosis (Grade B)”
Why: A sleeve worn early reduced progression to lasting lymphoedema in a randomised trial.
“2.17 When subclinical/early stage lymphoedema is detected in a prospective surveillance program, compression sleeves are suggested to be prescribed for at least 4–6 weeks. A longer duration can be considered depending on clinical response and the individual judgement of the treating therapist. Consensus achieved in round 2 96.2% (50/52)”
Multinational Association of Supportive Care in Cancer 2024 · Consensus 96.2%
Why: Treating swelling before it is visible lowered the chance of it becoming long-lasting in a randomised trial.
“S-BCRL detection triggered a 4-week, 12-hour per day, compression sleeve, and gauntlet intervention.”
Why: Larger swelling needs specialist lymphoedema treatment rather than a sleeve alone.
“2.8 In a prospective surveillance program, more intensive treatment (e.g., congestive decompressive therapy) is indicated when a difference in volume measurements is ≥ 10% compared to pre-surgery values Consensus achieved in round 2 91.7% (44/48)”
Multinational Association of Supportive Care in Cancer 2024 · Consensus 91.7%
Why: A well-fitted garment with exercise controls early swelling for most people.
“If early signs and/or symptoms of lymphedema are noted, the patient should be individually fitted with a compression garment, instructed in an exercise program, and provided education as first-line treatment. (Grade A)”
APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 · Grade A
Why: Bandaging reduces the swelling; the home programme keeps it down.
“CDT should be used to reduce limb volume in those diagnosed with moderate and late BCRL. (Grade B) • Compression bandaging and exercise are key components of CDT and should be used. (Grade A)”
APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 · Grade B (CDT); Grade A (bandaging and exercise within CDT)
Why: Lifting weights, built up gradually, does not cause or worsen lymphoedema and improves strength.
“Progressive resistance training is safe when an individualized program is supervised beginning at least 1 month postsurgery. (Grade A) Individualized aerobic exercise programs should be provided. (Grade A) Monitoring for exercise tolerance and adverse effects should initially occur at least weekly and then taper according to clinical presentation. (Grade A)”
APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 · Grade A
Why: Cellulitis in the at-risk arm was linked to arm swelling in a large cohort.
“This study suggests that although cellulitis increases risk of lymphedema, ipsilateral blood draws, injections, blood pressure readings, and air travel may not be associated with arm volume increases.”
Journal of Clinical Oncology 2016 · Prospective cohort (not a guideline grade)
Why: Skin infection (cellulitis) is a proven risk; many of the traditional prohibitions are not supported by research and can make people anxious.
“Patient education about precautionary risks needs to be concordant with what is currently evidenced in the literature.”
How care is usually carried out, read from the guidelines and standards cited. Your own team's protocol and their judgement come first; this page is for understanding it, not for doing it yourself.
Prospective surveillance from a preoperative baseline, with a compression sleeve when subclinical change appears, is the best-supported approach: MASCC 2024 recommends it by consensus on trial evidence (93.8% agreement), APTA 2020 recommends it (Grade C, because the evidence then was mostly observational) and the PREVENT randomised trial (2022) showed bioimpedance-triggered compression reduced progression to chronic lymphoedema against tape-measure-triggered compression. Exercise, including progressive resistance training, is safe (APTA Grade A). Treatment of established lymphoedema follows APTA 2020 by stage (Grade A for garment, exercise and education in early disease; Grade B for CDT later). On the arm precautions, the 2024 summit evidence map and consensus move away from blanket prohibitions on the same evidence: blood draws, injections, blood pressure readings and air travel were not associated with arm volume increase in the largest cohort, whereas infection was. The 2017 ASBrS panel, which also addressed them, could not be read, so the two cannot be set side by side here. MASCC and APTA differ on prophylactic sleeves: MASCC offers them as an option to anyone at risk, while APTA grades a fitted garment for high-risk patients, paired with exercise, at B.
Multinational Association of Supportive Care in Cancer 2024 · APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 · Lymphatic Research and Biology 2022 · Annals of Surgical Oncology 2024 · APTA Oncology Section, Physical Therapy 2017 · Medical Oncology (2023 ACS/LANA Lymphedema Summit) 2024 · Medical Oncology (2023 ACS/LANA Lymphedema Summit) 2024 · Journal of Clinical Oncology 2016 · American Society of Breast Surgeons, Annals of Surgical Oncology 2017
Where it differs: Teaches every person at risk to avoid any procedure or exposure on the treated side, for life.
Evidence: Common practice. In the Ferguson cohort none of blood draws, injections, blood pressure readings or flying was associated with arm volume increase. The 2024 evidence map (37 studies, 2008 to 2023) found evidence sufficient to refute many previously claimed risk factors for developing lymphoedema, and little evidence either way on progression once it exists. The 2024 ACS/LANA consensus updated recommendations on blood pressure, skin puncture, blood draws, air travel and heat; its specific wording could not be read (abstract only).
Journal of Clinical Oncology 2016 · Medical Oncology (2023 ACS/LANA Lymphedema Summit) 2024 · Medical Oncology (2023 ACS/LANA Lymphedema Summit) 2024
Where it differs: Circumference measured with a tape at set points, converted to volume, instead of a bioimpedance device.
Evidence: In PREVENT, tape measurement triggered intervention more often (27.5 against 20.1 per cent) and more of those treated progressed (19.2 against 7.9 per cent). Tape measurement needs no device and is widely available, and MASCC accepts it where bioimpedance is not available.
Lymphatic Research and Biology 2022 · Multinational Association of Supportive Care in Cancer 2024
Where it differs: Starts within 3 months of surgery, measures every 3 to 4 months in the first year, then every 6 to 12 months, for at least 24 months (APTA: every 3 months in the first year, then twice a year for up to 5 years).
Evidence: MASCC 2024 Delphi consensus: 85.9% (interval), 82.8% (start within 3 months), 89.1% (at least 24 months). PREVENT's timing analysis advises at least 3 years.
Multinational Association of Supportive Care in Cancer 2024 · APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 · Annals of Surgical Oncology 2024
Where it differs: Adds a 12-week supervised multimodal exercise programme to surveillance in high-risk women having adjuvant chemotherapy.
Evidence: Single-centre randomised trial of 116 women: the combination reduced arm volume and improved grip strength, walking distance and quality of life over surveillance alone. Read as an abstract.
Where it differs: Fits a sleeve from the first day after surgery until 3 months after the end of chemotherapy or radiotherapy (not hormone therapy), at least 8 hours a day.
Evidence: Offered as an option by MASCC 2024 (80% agreement, on a single randomised trial; experts who disagreed said one trial should not set routine practice); APTA 2020 Grade B for a fitted garment with exercise in high-risk patients.
Multinational Association of Supportive Care in Cancer 2024 · APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020
Where it differs: Adds therapist-delivered lymphatic drainage massage after surgery to prevent lymphoedema.
Evidence: APTA 2020: may not reduce the risk (Grade C).
APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020
Where it differs: Spares the arm's lymphatics during dissection, or joins divided lymphatics to a vein at the time of dissection.
Evidence: MASCC 2024: an option where expertise is available and resources allow; reverse mapping not for people at high risk of axillary recurrence.
Arm swelling after breast cancer surgery is common and lifelong once established, but if caught early with simple measurements and treated with a sleeve, most cases can be prevented from becoming permanent.
Many people treated for breast cancer are told never to have blood pressure taken, blood drawn or an injection in the arm on the treated side, and to wear a sleeve when flying. A 2024 review of 37 studies found the evidence sufficient to refute many of these supposed risks; skin infection remains a real one. The change is to teach what is proven, drop what is not, and test that it does no harm.
| Recommendation | Grade, as printed | Source |
|---|---|---|
| Prospective surveillance is recommended where feasible “2.1 A prospective surveillance program is recommended to reduce risks of chronic lymphoedema after breast cancer surgery where feasible and resources allow Consensus achieved in round 1 93.8% (60/64)” | Consensus 93.8% (MASCC) | Multinational Association of Supportive Care in Cancer 2024 |
| Prospective surveillance in high-risk groups “Early identification of subclinical lymphedema in high-risk groups through prospective surveillance may improve outcomes. (Grade C)” | Grade C | APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 |
| A pre-surgical baseline is required for surveillance “2.11 Pre-surgical assessment of lymphoedema is required in a prospective surveillance program for better comparison of measurements after surgery Consensus achieved in round 1 89.1% (57/64)” | Consensus 89.1% (MASCC) | Multinational Association of Supportive Care in Cancer 2024 |
| Surveillance every 3 to 4 months in year 1, then every 6 to 12 months “2.12 The surveillance interval for a prospective surveillance program is recommended to be every 3–4 months in the first year then every 6–12 months thereafter where feasible and resources allow Consensus achieved in round 1 85.9% (55/64)” | Consensus 85.9% (MASCC) | Multinational Association of Supportive Care in Cancer 2024 |
| Bioimpedance cut-offs for diagnosis “Cutpoint of >7.1 L-Dex score should be used for diagnosis of breast cancer–related lymphedema when preoperative baseline measures are not available (Grade B) – Cutpoint of >10 L-Dex score above preoperative baseline should be used for diagnosis of breast cancer–related lymphedema (Grade B)” | Grade B | APTA Oncology Section, Physical Therapy 2017 |
| Bioimpedance-triggered compression reduced progression against tape measure “Overall, 14.4% ( n = 30) progressed post-intervention, with reduced likelihood for BIS patients than TM patients (7.9%, n = 7 vs. 19.2%, n = 23; relative risk = 0.41; 95% CI, 0.13-0.81; absolute reduction 11.3%; 95% CI, 2.3-20.3; p = 0.016).” | randomised trial, P = 0.016 | Lymphatic Research and Biology 2022 |
| Prophylactic sleeves offered as an option “3.1 Prophylactic compression sleeves should be offered as an option to prevent breast cancer- related arm lymphoedema Consensus achieved in round 2 80% (40/50)” | Consensus 80% (MASCC) | Multinational Association of Supportive Care in Cancer 2024 |
| Fitted compression garment with exercise for high-risk patients “Provision of a fitted compression garment to patients at high risk of developing lymphedema, when paired with upper extremity exercise and diaphragmatic breathing, may reduce development of lymphedema. (Grade B)” | Grade B (APTA) | APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 |
| Manual lymphatic drainage after axillary dissection does not clearly prevent lymphoedema “The addition of therapist-provided manual lymphatic drainage (MLD) to the postoperative care plan may not reduce the risk of developing BCRL. (Grade C)” | Grade C | APTA Academy of Oncologic Physical Therapy, Physical Therapy 2020 |
| Weight lifting does not increase lymphoedema “In breast cancer survivors at risk for lymphedema, a program of slowly progressive weight lifting compared with no exercise did not result in increased incidence of lymphedema.” | Randomised equivalence trial, n=154 (PAL) | JAMA 2010 |
| Evidence too thin for other cancers “More high-quality evidence is required to allow the development of risk reduction recommendations for other cancer types such as gynecological, melanoma, and head and neck.” | Consensus statement (ACS/LANA) | Medical Oncology (2023 ACS/LANA Lymphedema Summit) 2024 |
Shares Follow-up after treatment for early breast cancer and the tags protocol, survivorship.
Shares Breast cancer (all types) and the tags protocol, survivorship.
Shares the tags protocol, survivorship.
Shares the tags protocol, survivorship.
Shares the tags protocol, survivorship.
Shares the tags protocol, survivorship.
Shares the tags protocol, survivorship.
Shares the tags protocol, survivorship.